TipRanks
Go Ultimate55% OFF

AFC Gamma (0FG) AI Stock Analysis

DE:0FG

AFC Gamma

(Frankfurt:0FG)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Senior-secured portfolioThe first-lien structure gives AFCG priority claims on collateral, while the 13.2% weighted-average yield supports recurring interest income. This combination can protect recoveries and sustain earnings power as the portfolio is managed and legacy exposures are resolved.
Negative Factors
Negative cash generationNegative operating and free cash flow weaken the connection between reported earnings and internally generated funding. If the cash deficit persists, AFCG may need additional borrowing, asset repayments, or capital actions to support new originations and maintain financial flexibility.

AFC Gamma (0FG) vs. iShares MSCI Germany ETF (EWG)

-40%-30%-20%-10%0%10%20%30%DE:0FG+1.74%EWG+6.61%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
EUR 67.18M
Dividend Yield
4.98%
Average Volume (3M)
400
Price to Earnings (P/E)
15.7
Beta (1Y)
0.74
Revenue Growth
-14.29%
EPS Growth
―
Country
Germany
Employees
26
Sector
Financial
Sector Strength
68
Industry
Asset Management

AFC Gamma Business Overview & Revenue Model

Company Description

Advanced Flower Capital Inc. originates, structures, underwrites, invests in, and manages senior secured loans and other types of mortgage loans and debt securities for established companies operating in the cannabis industry. It primarily originates...

AFC Gamma Earnings Call Summary

Earnings Call Date:Aug 12, 2026(Q2-2026)|% Change Since:13.64%|Next Earnings Date:Nov 04, 2026
Earnings Call SentimentPositive

The call conveyed constructive operational progress: NAV increased, share repurchases were accretive, portfolio yield remains attractive (13.2%), liquidity is ample (~$106.5M cash and >$70M deployable), and the company is actively redeploying into non-cannabis lower middle market opportunities (1.3B pipeline). Offsetting these positives are concentrated legacy cannabis non-accruals (including an active default and foreclosure), a quarter-over-quarter dip in reported investment income due to Q1 episodic exit fees, and originations that were lumpy and slower in Q2. Management has made tangible progress on legacy recoveries (Devi and DMA) and improved post-quarter leverage via revolver repayments, which supports a cautiously optimistic outlook.

Positive Updates

Net Investment Income and Distribution Coverage
Net investment income of $3.5M, or $0.15 per weighted average share for Q2 2026, providing 3x coverage of the $0.05 quarterly distribution paid on 07/15/2026.

Negative Updates

Legacy Cannabis Non-Accrual Concentration and Defaults
Non-accrual loans remain concentrated in the legacy cannabis book. Justice Grown loan matured 05/01/2026 and is in maturity default; AFC has commenced Article 9 foreclosures and engaged SSG Advisors to market assets. Active litigation limits disclosure and creates uncertainty around ultimate recoveries.

Company Guidance

Management guided that they remain focused on redeploying capital into the lower middle market where they see attractive, disciplined opportunities, noting a $1.3 billion pipeline and ~$102 million of YTD new commitments while cautioning originations will be lumpy; they said they have ample capacity to act with over $70 million of deployable liquidity, $106.5 million of cash and cash equivalents, and the ability to co‑invest or syndicate larger transactions. Key Q2 metrics cited include NAV of $8.25 (+$0.35 q/q) with net assets of $187.3 million and total assets of $399.7 million, principal outstanding of $364.5 million across 17 loans, portfolio fair value $290 million, 100% senior‑secured first‑lien positioning and a weighted‑average yield (ex‑nonaccruals) of 13.2%; operating results were $8.7 million of total investment income and $3.5 million of net investment income ($0.15/share), providing 3x coverage of the $0.05/share distribution. Balance‑sheet and capital‑management metrics highlighted: $207 million of debt outstanding ( $110M secured revolver, $20M unsecured revolver, $77M senior notes) at a 6.3% weighted average rate, debt/equity 1.1x, net debt/equity 0.53x, asset coverage 190% (vs 150% requirement), Q2 buybacks of ~$2.8M (839k shares at $3.29; $0.17 NAV accretion) with $2.2M remaining under the $5M program. Management reiterated focus on cash‑flowing borrowers with $5M–$50M EBITDA, continued resolution of legacy cannabis non‑accruals (Devi sale for $12.5M with $2M deposit and ~80% participation; $58M principal repaid to date; DMA asset sales closed; Justice Grown in foreclosure), and a stated intermediate leverage target around 1.0x.

AFC Gamma Risk Analysis

AFC Gamma disclosed 92 risk factors in its most recent earnings report. AFC Gamma reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

AFC Gamma Peers Comparison

Overall Rating

UnderperformOutperform
Sector (68)

Financial Indicators

DE:0FG against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *68Neutral$18.00B11.429.92%3.81%9.73%1.22%
FPIFPI56Neutral$353.88M35.602.17%6.18%-5.57%-85.35%

* Financial Sector Average

Performance Comparison

-25%0%25%50%75%DE:0FGPWFPIDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
DE:0FG and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:0FGAdvanced Flower Capital Inc.2.630.031.00%
PWPower REIT6.940.010.10%
FPIFarmland Partners8.58-0.81-8.63%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.